Skeletal Radiology

, Volume 46, Issue 8, pp 1143–1147 | Cite as

Myxofibrosarcoma: First report of myxofibrosarcoma of bone arising at a bone infarct

  • Dietrich Kayser
  • Zeke Walton
  • Evelyn Bruner
  • Russell W. Chapin
Case Report


Approximately 3300 new primary bone tumors will present to American physicians this year. This small but important group of malignancies has become more defined with developments in pathologic morphology, immunohistochemistry, and molecular studies. As tumor types are better partitioned, their specific characteristics are more readily observed. In this article we present the first reported case of a myxofibrosarcoma of bone developing within a bone infarct. With improved delineation of rarer tumor types, it is expected that additional cases of myxofibrosarcoma of bone will be recognized, potentially arising from a bone infarct. By framing the context, describing the case, and sharing pertinent figures, we hope to facilitate this recognition.


Sarcoma Osteonecrosis 


Compliance with ethical standards

Sources of support



The views expressed in the submitted article are not an official position of the institution or funder.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Furey JG, Ferrer-Torells M, Reagan JW. Fibrosarcoma arising at the site of bone infarcts. A report of 2 cases. J Bone Joint Surg Am. 1960;42(5):802–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Frassica FJ, Sim FH, Wold LE. Case report 462. Skelet Radiol. 1988;17(1):77–80.CrossRefGoogle Scholar
  4. 4.
    Stacy GS, Lo R, Montag A. Infarct-associated bone sarcomas: multimodality imaging findings. Am J Roentgenol. 2015;205(4):W432–41.CrossRefGoogle Scholar
  5. 5.
    Wada T, Hasegawa T, Nagoya S, Kawaguchi S, Kaya M, Ishii S. Myxofibrosarcoma with an infiltrative growth pattern: a case report. Jpn J Clin Oncol. 2000;30(10):458–62.CrossRefPubMedGoogle Scholar
  6. 6.
    Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, et al. Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20(4):391–405.CrossRefPubMedGoogle Scholar
  7. 7.
    Willems SM, Debiec-Rychter M, Szuhai K, Hogendoorn PC, Sciot R. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol. 2006;19(3):407–16.CrossRefPubMedGoogle Scholar
  8. 8.
    Romeo S, Bovée JV, Kroon HM, Tirabosco R, Natali C, Zanatta L, et al. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch. 2012;461(5):561–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.Google Scholar
  10. 10.
    Murphey MD, Gross TM, Rosenthal HG. From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation. Radiographics. 1994;14(4):807–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier/Saunders; 2014.Google Scholar

Copyright information

© ISS 2017

Authors and Affiliations

  • Dietrich Kayser
    • 1
  • Zeke Walton
    • 2
  • Evelyn Bruner
    • 3
  • Russell W. Chapin
    • 4
  1. 1.Medical University of South CarolinaCharlestonUSA
  2. 2.Department of OrthopaedicsMedical University of South CarolinaCharlestonUSA
  3. 3.Department of Pathology and Laboratory MedicineMedical University of South CarolinaCharlestonUSA
  4. 4.Department of Radiology and Radiological ScienceMedical University of South CarolinaCharlestonUSA

Personalised recommendations